Wambeke David J. 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 26, 2023
Insider Transaction Report
Form 4
Wambeke David J.
Chief Business Officer
Transactions
- Purchase
Voting Common Shares, no par value per share
2023-06-23$3.91/sh+38,364$150,003→ 507,114 total